GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
115 hedge funds and large institutions have $1.39B invested in G1 Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 47 increasing their positions, 21 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
99% less call options, than puts
Call options by funds: $5K | Put options by funds: $675K
Holders
115
Holding in Top 10
1
Calls
$5K
Puts
$675K
Top Buyers
| 1 | +$38.9M | |
| 2 | +$28.7M | |
| 3 | +$19.9M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$16.4M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$13.9M |
Top Sellers
| 1 | -$6.48M | |
| 2 | -$6.01M | |
| 3 | -$5.25M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$5.03M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$4.16M |